Skip to main content

Table 7 Multivariate analysis of clinical features and ERβ1 expression with disease specific survival

From: Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival

Feature (reference)

HR [CI 95%]

p value

ERβ1 > 40% (vs. ERβ1 < 40%)

1.13 [0.51–2.51]

0.762

Agea

1.03 [1.00–1.06]

0.044*

Stage IIA

3.49 [0.97–12.52]

0.056

Stage IIB

4.75 [1.17–19.36]

0.029*

Stage III/IV

4.42 [1.08–18.04]

0.038*

Chemotherapy yes (va. no)

0.61 [0.25–1.52]

0.288

  1. Footnote: aContinuous (years). * P<0.05
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us